SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-019416
Filing Date
2017-04-06
Accepted
2017-04-06 16:02:31
Documents
6
Period of Report
2017-05-04
Effectiveness Date
2017-04-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A v463693_def14a.htm DEF 14A 304889
2 GRAPHIC image_001.jpg GRAPHIC 3639
3 GRAPHIC image_002.jpg GRAPHIC 109360
4 GRAPHIC image_003.jpg GRAPHIC 114146
5 GRAPHIC image_rbksignature.jpg GRAPHIC 4808
6 GRAPHIC emoylesignature.jpg GRAPHIC 4715
  Complete submission text file 0001144204-17-019416.txt   632667
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35023 | Film No.: 17745987
SIC: 2834 Pharmaceutical Preparations